NOD2 and acute myeloid leukemia: First in an in vitro then an animal in vivo study, treatment with a combination of IFN-γ (interferon-gamma) and MTP-PE (muramyl tripeptide phosphatidylethanolamine - a synthetic molecule that binds to NOD2) on AML brought on a cytokine response that activated NK cell production [7].